Zn/Cu Bi‐Single‐Atom Nanoplatform: Hexagonal Anti‐Tumor Warrior by ROS Amplification for DOX Resistance Reversal and Immune Activation
- 30 September 2024
- journal article
- research article
- Published by Wiley in Advanced Functional Materials
- Vol. 34 (52)
Abstract
Severe resistance of doxorubicin (DOX) caused by drug efflux and immunosuppression has led to a high treatment failure risk of breast cancer (BC). Compared with the single atom nanozymes, the bi‐single‐atomic nanozymes obtained through sequential single‐atom synthesis strategy in different spaces of the same nanomaterial, can significantly improve the space utilization efficiency and catalytic capacity. In this study, bi‐single‐atom nanozymes (Zn/Cu‐BSAN‐DOX NPs) are designed to reverse BC DOX resistance by causing damage to mitochondria of mesenchymal stem cells (MSCs) and 4T1 cells through reactive oxygen species (ROS) amplification. In situ H2O2 self‐supply is improved by releasing DOX through activating the nicotinamide adenine dinucleotide phosphate (NADPH) oxidases (NOXs). ROS amplification is triggered by enhanced chemodynamic therapy (CDT) and sonodynamic therapy (SDT) of Zn/Cu‐BSAN, which efficiently reverses the DOX resistance by breaking the hyaluronic acid (HA) barrier and DOX efflux. Furthermore, ROS amplification significantly promotes the immune improvement including DCs maturation, T cell activation, and the polarization of M1 macrophage. In summary, as “hexagonal” anti‐tumor warrior, Zn/Cu‐BSAN‐DOX NPs show great potential for multimodal DOX‐resistant BC therapy, which further expands the new preparation strategy and the clinical anti‐tumor application paradigm of single‐atom nanozymes.Keywords
Funding Information
- Natural Science Foundation of Shandong Province (ZR2022MH187)
- National Natural Science Foundation of China (32101137)
- Fundação para a Ciência e a Tecnologia (10.54499/2022.05711, 10.5499/2022.05737.PTDC)
This publication has 62 references indexed in Scilit:
- Mn Single‐Atom Nanozyme Functionalized 3D‐Printed Bioceramic Scaffolds for Enhanced Antibacterial Activity and Bone RegenerationAdvanced Healthcare Materials, 2024
- Single‐Atom Nanozymes for Catalytic Therapy: Recent Advances and ChallengesAdvanced Functional Materials, 2024
- Asymmetric Coordination of Iron Single‐Atom Nanozymes with Efficient Self‐Cascade Catalysis for Ferroptosis TherapyAdvanced Functional Materials, 2023
- NIR‐II Photothermal Activation of TRPV1 Channels for Intracellular Magnesium Regulation by Porous Pd@Pt Core–Shell Nanostructure to Reverse Tumor Multidrug ResistanceAdvanced Functional Materials, 2023
- Copper‐Single‐Atom Coordinated Nanotherapeutics for Enhanced Sonothermal‐Parallel Catalytic Synergistic Cancer TherapyAdvanced Healthcare Materials, 2023
- Geometric and Electronic Structure‐Matched Superoxide Dismutase‐Like and Catalase‐Like Sequential Single‐Atom Nanozymes for Osteoarthritis RecessionAdvanced Functional Materials, 2022
- H2O2 Self‐Producing Single‐Atom Nanozyme Hydrogels as Light‐Controlled Oxidative Stress Amplifier for Enhanced Synergistic Therapy by Transforming “Cold” TumorsAdvanced Functional Materials, 2022
- Supramolecular Self‐Assembly‐Facilitated Aggregation of Tumor‐Specific Transmembrane Receptors for Signaling Activation and Converting Immunologically Cold to Hot TumorsAdvanced Materials, 2021
- Bioinspired Copper Single‐Atom Catalysts for Tumor Parallel Catalytic TherapyAdvanced Materials, 2020
- A Tumor‐Specific Cascade Amplification Drug Release Nanoparticle for Overcoming Multidrug Resistance in CancersAdvanced Materials, 2017